Quantum-Si Announces Presentations at ASMS and ESHG

Rhea-AI Summary

Quantum-Si (Nasdaq: QSI) announced upcoming presentations at two industry conferences. Dr. Gloria Sheynkman's lab will present at the ASMS annual meeting on June 2-6, 2024, highlighting the integration of single-molecule detection with proteogenomics to detect peptides. Dr. Brian Reed will present at the ESHG annual meeting on June 1-4, 2024, discussing the role of Next-Generation Protein Sequencing (NGPS) in advancing biological research. The Platinum® platform, a compact protein sequencer from Quantum-Si, will be featured for its ability to sequence proteins with single-amino-acid resolution.

Positive

• Quantum-Si is presenting at prominent industry conferences (ASMS and ESHG), increasing visibility.
• The Platinum platform offers single-amino-acid resolution in protein sequencing, a significant technological advancement.
• Integration of single-molecule detection with proteogenomics for detecting proteotypic and isoform-selective peptides is groundbreaking.
• The compact and affordable Platinum device enables more researchers to conduct advanced protein sequencing in their labs.
• Dr. Brian Reed's presentation at ESHG will discuss how NGPS technology is advancing biological research.

Negative

• No immediate financial data or revenue impacts disclosed in the PR, leaving investors uncertain about commercial benefits.
• The PR lacks specific data on how the new technology and presentations may translate into market share or profitability.
• Potential risk if the market does not widely adopt the Platinum platform despite its technological advancements.

BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced presentations at two upcoming industry conferences. Gloria Sheynkman, PhD, Assistant Professor in the Department of Molecular Physiology and Biological Physics at the University of Virginia’s lab will present a poster developed in collaboration with Quantum-Si at the American Society for Mass Spectrometry (ASMS) annual meeting being held June 2-6, 2024. Dr. Brian Reed, Head of Research at Quantum-Si will present at the European Society for Human Genetics (ESHG) annual meeting being held June 1-4, 2024.

Results of the study to be presented, by Natchanon Sittipongpittaya from Dr. Sheynkman’s lab at ASMS, represent the first integration of single-molecule detection methods with proteogenomics to detect proteotypic and isoform-selective peptides.

Long read transcriptomics (LR-RNA-seq) revealed multiple annotated and novel isoforms (i.e., spliceforms) of vimentin, TPM1 and TPM2. Like many alternatively spliced isoforms, much of the predicted protein sequences are highly overlapping and difficult to distinguish. Additionally, TPM1 and TPM2, being closely related paralogs, also have high sequence identity (87%). Using the Platinum platform, protein sequencing distinguished isoform-specific peptides for filament proteins involved in cancer and skeletal muscle diseases.

At ESHG, Dr. Reed will discuss the expanding role of Next-Generation Protein Sequencing™ (NGPS) in advancing biological research by enabling any researcher to sequence proteins in their lab. Quantum-Si’s protein sequencer, Platinum®, is a compact and affordable benchtop device that enables direct sequencing of proteins with single-amino-acid resolution using a simple workflow. NGPS is a transformative technology that enables direct interrogation of protein primary structure, post-translational modifications (PTMs), and protein isoform diversity.

Presentation details are as follows:

ASMS

Title: Integrated sequencing of transcripts and proteins at the single molecule level to detect isoforms and proteolytic peptides in filament biomarkers

Session: Proteomics: New Approaches

Authors: Gloria Shenykman, PhD and Natchanon Sittipongpittaya, both of the University of Virginia and Kenneth Skinner, PhD, Quantum-Si

Date and Time: June 3, 10:30 am - 12:30 pm and 1:30 - 2:30 pm PDT

ESHG

Title: Beyond the Genome: Unlocking Proteomic Discoveries with Quantum-Si’s Next-Generation Protein Sequencing™ Technology

Presenter: Brian Reed, PhD

Date and Time: Sunday, June 2, 8:30 -10:00 a.m. BST

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantum-si.com or follow us on LinkedIn or X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240531086657/en/

Investor Contact

Jeff Keyes, Chief Financial Officer

ir@quantum-si.com



Media Contact

Katherine Atkinson, SVP, Commercial Marketing

media@quantum-si.com

 

Source: Quantum-Si Incorporated

FAQ

What will Quantum-Si present at the ASMS annual meeting?

Quantum-Si will highlight the integration of single-molecule detection methods with proteogenomics to detect proteotypic and isoform-selective peptides.

When is Quantum-Si presenting at the ASMS annual meeting?

Quantum-Si's presentation at the ASMS annual meeting is scheduled for June 2-6, 2024.

Who will present for Quantum-Si at the ASMS annual meeting?

Natchanon Sittipongpittaya from Dr. Gloria Sheynkman's lab will present on behalf of Quantum-Si.

What is the focus of Dr. Brian Reed's presentation at the ESHG annual meeting?

Dr. Brian Reed will discuss the expanding role of Next-Generation Protein Sequencing (NGPS) in advancing biological research.

When is Quantum-Si presenting at the ESHG annual meeting?

Quantum-Si's presentation at the ESHG annual meeting is scheduled for June 1-4, 2024.

What technology will be featured by Quantum-Si at the ESHG annual meeting?

Quantum-Si will feature their Platinum® platform, a compact and affordable benchtop device for direct protein sequencing.

What are the benefits of Quantum-Si's Platinum platform?

The Platinum platform enables direct sequencing of proteins with single-amino-acid resolution, offering significant advancements in biological research.

What proteins are being studied using Quantum-Si's technology?

Quantum-Si's technology is used to study filament proteins involved in cancer and skeletal muscle diseases.